References
- Zhang LY, Pang SS, Deng B, et al. High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. Int J Biochem Cell B 2012;44:629–38
- Ha H, Lee HB. Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol 2003;14:S246–9
- Abboud HE. Mesangial cell biology. Exp Cell Res 2012;318:979–85
- Cohen MP, Hud E, Wu VY, Ziyadeh FN. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription. Mol Cell Biochem 1995;151:61–7
- Kikkawa R, Koya D, Haneda M. Progression of diabetic nephropathy. Am J Kidney Dis 2003;41:S19–21
- Ha H, Yu MR, Choi YJ, et al. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 2002;13:894–902
- Ha H, Lee HB. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 2000;58:S19–25
- Ha H, Kim KH. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int 1995:S18–21
- Sun L, Li WP, Li WZ, et al. Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF-κB pathway under high glucose conditions. Int J Mol Med 2014;34:167–76
- Navarro-González JF, Mora-Fernández C, de Fuentes MM, García-Pérez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 2011;7:327–40
- Jia QQ, Wang JC, Long J, et al. Sesquiterpene lactones and their derivatives inhibit high glucose-induced NF-κB activation and MCP-1 and TGF-β1 expression in rat mesangial cells. Molecules 2013;18:13061–77
- Nishibe S, Kinoshita H, Takeda H, Okano G. Phenolic compounds from stem bark of Acanthopanax senticosus and their pharmacological effect in chronic swimming stressed rats. Chem Pharm Bull 1990;38:1763–5
- Yu CY, Kim SH, Lim JD, et al. Intraspecific relationship analysis by DNA markers and in vitro cytotoxic and antioxidant activity in Eleutherococcus senticosus. Toxicol In Vitro 2003;17:229–36
- Schmolz MW, Sacher F, Aicher B. The synthesis of Rantes, G-CSF, IL-4, IL-5, IL-6, IL-12 and IL-13 in human wholeblood cultures is modulated by an extract from Eleutherococcus senticosus L. roots. Phytother Res 2001;15:268–70
- Ahn J, Um MY, Lee H, et al. Eleutheroside E, an active component of Eleutherococcus senticosus, ameliorates insulin resistance in type 2 diabetic db/db mice. Evid Based Compl Alt 2013;2013:934183
- Kleniewska P, Piechota A, Skibska B, Gorąca A. The NADPH oxidase family and its inhibitors. Arch Immunol Ther Exp 2012;60:277–94
- Al-Kafaji G, Golbahar J. High glucose-induced oxidative stress increases the copy number of mitochondrial DNA in human mesangial cells. Biomed Res Int 2013;2013:754946
- Ohtsu H, Frank GD, Utsunomiya H, Eguchi S. Redox-dependent protein kinase regulation by angiotensin II: mechanistic insights and its pathophysiology. Antioxid Redox Signal 2005;7:1315–26
- Asaba K, Tojo A, Onozato ML, et al. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 2005;67:1890–8
- Nam SM, Lee MY, Koh JH, et al. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property. Diabetes Res Clin Pract 2009;83:176–82
- Wang JC, Zhao Y, Chen SJ, et al. AOPPs induce MCP-1 expression by increasing ROS-mediated activation of the NF-κB pathway in rat mesangial cells: inhibition by sesquiterpene lactones. Cell Physiol Biochem 2013;32:1867–77
- Siomek A. NF-κB signaling pathway and free radical impact. Acta Biochim Pol 2012;59:323–31
- Guijarro C, Egido J. Transcription factor-κB (NF-κB) and renal disease. Kidney Int 2001;59:415–24
- Banba N, Nakamura T, Matsumura M, et al. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 2000;58:684–90
- Ihm CG, Park JK, Hong SP, et al. High glucose stimulates the expression of monocyte chemotactic peptide-1 in human mesangial cells. Nephron 1998;79:33–7
- Giunti S, Tesch GH, Pinach S, et al. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2008;51:198–207
- Verhelst K, Verstrepen L, Carpentier I, Beyaert R. IkB kinase e (IKKe). A therapeutic target in inflammation and cancer. Biochem Pharmacol 2013;85:873–80